These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8723225

  • 1. Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice.
    Power C, Kong PA, Trapp BD.
    J Neurosci Res; 1996 Apr 15; 44(2):165-73. PubMed ID: 8723225
    [Abstract] [Full Text] [Related]

  • 2. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes.
    Turnley AM, Morahan G, Okano H, Bernard O, Mikoshiba K, Allison J, Bartlett PF, Miller JF.
    Nature; 1991 Oct 10; 353(6344):566-9. PubMed ID: 1717849
    [Abstract] [Full Text] [Related]

  • 3. Model for focal demyelination of the spinal dorsal columns of transgenic MBP-LacZ mice by phototargeted ablation of oligodendrocytes.
    Vanderluit JL, Bourque JA, Peterson AC, Tetzlaff W.
    J Neurosci Res; 2000 Oct 01; 62(1):28-39. PubMed ID: 11002285
    [Abstract] [Full Text] [Related]

  • 4. Transgenic mouse model for central nervous system demyelination.
    Yoshioka T, Feigenbaum L, Jay G.
    Mol Cell Biol; 1991 Nov 01; 11(11):5479-86. PubMed ID: 1717829
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.
    Caprariello AV, Batt CE, Zippe I, Romito-DiGiacomo RR, Karl M, Miller RH.
    J Neurosci; 2015 Oct 14; 35(41):14031-41. PubMed ID: 26468203
    [Abstract] [Full Text] [Related]

  • 6. Dysmyelination in class I MHC transgenic mice.
    Turnley AM, Morahan G.
    Microsc Res Tech; 1995 Nov 01; 32(4):286-94. PubMed ID: 8573778
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development.
    Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B.
    Mol Cell Neurosci; 1996 May 01; 7(5):354-70. PubMed ID: 8812062
    [Abstract] [Full Text] [Related]

  • 9. On the occurrence of hypomyelination in a transgenic mouse model: a consequence of the myelin basic protein promoter?
    Gaupp S, Arezzo J, Dutta DJ, John GR, Raine CS.
    J Neuropathol Exp Neurol; 2011 Dec 01; 70(12):1138-50. PubMed ID: 22082665
    [Abstract] [Full Text] [Related]

  • 10. Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes.
    Chen SC, Leach MW, Chen Y, Cai XY, Sullivan L, Wiekowski M, Dovey-Hartman BJ, Zlotnik A, Lira SA.
    J Immunol; 2002 Feb 01; 168(3):1009-17. PubMed ID: 11801633
    [Abstract] [Full Text] [Related]

  • 11. Major histocompatibility complex heavy chain accumulation in the endoplasmic reticulum of oligodendrocytes results in myelin abnormalities.
    Baerwald KD, Corbin JG, Popko B.
    J Neurosci Res; 2000 Jan 15; 59(2):160-9. PubMed ID: 10650874
    [Abstract] [Full Text] [Related]

  • 12. Delayed and incomplete myelination in a transgenic mouse mutant with abnormal oligodendrocytes.
    Orian JM, Slavin A, Ayers MM, Bernard CC.
    J Neurosci Res; 1997 Dec 01; 50(5):809-20. PubMed ID: 9418968
    [Abstract] [Full Text] [Related]

  • 13. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord.
    Rodriguez M, Lennon VA, Benveniste EN, Merrill JE.
    J Neuropathol Exp Neurol; 1987 Jan 01; 46(1):84-95. PubMed ID: 2432195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recovery of myelin after induction of oligodendrocyte cell death in postnatal brain.
    Jalabi W, Boehm N, Grucker D, Ghandour MS.
    J Neurosci; 2005 Mar 16; 25(11):2885-94. PubMed ID: 15772348
    [Abstract] [Full Text] [Related]

  • 17. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.
    Ryu JK, Petersen MA, Murray SG, Baeten KM, Meyer-Franke A, Chan JP, Vagena E, Bedard C, Machado MR, Rios Coronado PE, Prod'homme T, Charo IF, Lassmann H, Degen JL, Zamvil SS, Akassoglou K.
    Nat Commun; 2015 Sep 10; 6():8164. PubMed ID: 26353940
    [Abstract] [Full Text] [Related]

  • 18. MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis.
    Harrington EP, Catenacci RB, Smith MD, Heo D, Miller CE, Meyers KR, Glatzer J, Bergles DE, Calabresi PA.
    Elife; 2023 Apr 14; 12():. PubMed ID: 37057892
    [Abstract] [Full Text] [Related]

  • 19. Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model.
    Georgiou E, Sidiropoulou K, Richter J, Papaneophytou C, Sargiannidou I, Kagiava A, von Jonquieres G, Christodoulou C, Klugmann M, Kleopa KA.
    Brain; 2017 Mar 01; 140(3):599-616. PubMed ID: 28100454
    [Abstract] [Full Text] [Related]

  • 20. Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-gamma and TNF-alpha.
    Turnley AM, Miller JF, Bartlett PF.
    Neurosci Lett; 1991 Feb 11; 123(1):45-8. PubMed ID: 1712090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.